Trial Profile
Open, non comparative, prospectic, phase IV clinical study to evaluate the activity and tolerance of Cinacalcet-HCl (drug name Mimpara) in patients affected by MEN1-associated primary hyperparathyroidism
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2014
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Hyperparathyroidism
- Focus Therapeutic Use
- Acronyms IPERMEN
- 02 Jul 2014 New trial record